Receptors for Interleukin (IL)-4 Do Not Associate with the Common
Chain, and IL-4 Induces the Phosphorylation of JAK2 Tyrosine Kinase in Human Colon Carcinoma Cells (*)
- From the Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapy, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892
- § To whom correspondence should be addressed: Laboratory of Molecular Tumor Biology, HFM-530, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, National Institutes of Health Bldg. 29B, Rm. 2NN10, 29 Lincoln Dr., MSC 4555, Bethesda, MD 20892-4555. Tel.: 301-827-0471; Fax: 301-827-0449; PURI{at}A1.CBER.FDA.GOV.
Abstract
We have previously reported on the expression of interleukin-4 receptors (IL-4R) on many human epithelial cancer cells; however,
the binding characteristics, structure, function, and signal transduction through the IL-4R in cancer cells is not known.
IL-4 binding characteristics were determined in human colon carcinoma cell lines by a
I-IL-4 binding assay, which demonstrated that the HT-29 and WiDr colon cancer cell lines expressed high affinity IL-4R (K
= 200 pM). Cross-linking experiments revealed a major band of 140 kDa and a broad band at 70 kDa. While the common
chain of IL-2R is associated with IL-4R in immune cells and is similar in size to the 70-kDa protein, this chain was not expressed
in these colon cancer cells. Interestingly, IL-13, which has many functions similar to IL-4, inhibited
I-IL-4 binding to both the 140- and 70-kDa molecules. Next, we investigated the mechanism of IL-4-induced signal transduction
in colon cancer cells. After stimulation with IL-4, a 170-kDa band was primarily phosphorylated within 1 min of exposure and
was identified as insulin receptor substrate-1. In addition, by immunoprecipitation assay, three other phosphorylated bands
were identified as JAK1, JAK2, and Tyk2 tyrosine kinases. The phosphorylation of JAK1 and JAK2 was induced by IL-4 stimulation;
however, Tyk2 was constitutively phosphorylated, and IL-4 treatment further augmented this phosphorylation. The kinetics and
in vitro kinase assays demonstrated that JAK1, JAK2, and Tyk2 were phosphorylated within minutes and that JAK1 and JAK2 were activated
after IL-4 exposure. Contrary to observations in immune cells, JAK3 mRNA was neither detected in colon cancer cells nor did
IL-4 treatment cause phosphorylation of JAK3. These data indicate that in colon carcinoma cells JAK1, JAK2, Tyk2, and insulin
receptor substrate-1 are phosphorylated after IL-4 stimulation. In addition, as is the case in lymphoid cells, IL-4 activated
and phosphorylated signal transducers and activators of transcription (IL-4-STAT or STAT-6) protein in both colon cancer cell
lines. These results indicate that the IL-4R complex is composed of different subunits in different tissues and shares a component
with the IL-13R complex. In addition, we demonstrate for the first time that like its family members (e.g. IL-3 and GM-CSF), IL-4 can phosphorylate and activate JAK-2 kinase.
Footnotes
-
↵* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵1 The abbreviations used are:
- IL-4
-
interleukin-4
- IL-4R
-
IL-4 receptors
- IRS-1
-
insulin receptor substrate-1
- PAGE
-
polyacrylamide gel electrophoresis
- PVDF
-
polyvinylidene difluoride
- RCC
-
renal cell carcinoma.
-
↵2N. Obiri and R. K. Puri, manuscript in preparation.
-
- Received September 21, 1995.
- Revision received October 20, 1995.
- © 1996 by The American Society for Biochemistry and Molecular Biology, Inc.











